The Journal of Immunology, Vol 137, Issue 4 1275-1279, Copyright © 1986 by American Association of Immunologists

ARTICLES

Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF)

A Nicholson-Weller, DA Russian and KF Austen

Decay-accelerating factor (DAF) is a 75,000 m.w. membrane protein that inhibits autologous complement C3 activation at the cell surface. One- color direct immunofluorescence with anti-DAF antibody and cytofluorographic analysis indicates that normal human monocytes and granulocytes are uniform in expression of DAF, whereas 23% of peripheral blood lymphocytes are DAF deficient. A two-color indirect immunofluorescence method, used to define the phenotype(s) of the DAF- deficient lymphocytes, was less efficient in DAF detection and led to overestimation of the fraction of deficient cells. Nonetheless, the difference between DAF expression by natural killer cells, identified by the CD16 and HNK-1 antigens, was marked. DAF deficiency was intermediate in cells expressing the CD2, CD3, CD4, or CD8 markers. On the basis of the phenotypic definition of natural killer cells and their contribution to the lymphocyte population, it is concluded that a uniform deficiency of DAF on natural killer cells accounts for about one-half of the DAF-deficient lymphocytes in peripheral blood of normal donors. The finding of a complete DAF deficiency in the lymphocytes from a patient with a lymphoproliferative disorder with the predominant proliferation of CD2+, CD3+, CD8+, HNK-1+ large granular lymphocytes gives additional support for the association of DAF-deficiency with natural killer cells.

This article has been cited by other articles:

				S. Matsuba, H. Matsuno, M. Sakuma, and Y. Komatsu Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 85 - 90. [Abstract] [Full Text] [PDF]